Biotechnology-EMEA Market Status and Trend Report 2013-2023
Report Summary
Biotechnology-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biotechnology industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Biotechnology 2013-2017, and development forecast 2018-2023
Main market players of Biotechnology in EMEA, with company and product introduction, position in the Biotechnology market
Market status and development trend of Biotechnology by types and applications
Cost and profit status of Biotechnology, and marketing status
Market growth drivers and challenges
The report segments the EMEA Biotechnology market as:
EMEA Biotechnology Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Biotechnology Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA Sequencing
Nanobiotechnology
Tissue engineering and Regeneration
Fermentation
Cell Based Assay
PCR Technology
Chromatography Market
Others
EMEA Biotechnology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Health
Food & Agriculture
Natural Resources & Environment
Industrial Processing
Bioinformatics
Others
EMEA Biotechnology Market: Players Segment Analysis (Company and Product introduction, Biotechnology Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd
Pfizer
Merck & Co.
Sanofi
AstraZeneca
Gilead
CELGENE CORPORATION
Biogen
Amgen, Inc
Abbott
Novo Nordisk A/S
Novartis AG
Lonza
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Biotechnology-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biotechnology industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Biotechnology 2013-2017, and development forecast 2018-2023
Main market players of Biotechnology in EMEA, with company and product introduction, position in the Biotechnology market
Market status and development trend of Biotechnology by types and applications
Cost and profit status of Biotechnology, and marketing status
Market growth drivers and challenges
The report segments the EMEA Biotechnology market as:
EMEA Biotechnology Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Biotechnology Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA Sequencing
Nanobiotechnology
Tissue engineering and Regeneration
Fermentation
Cell Based Assay
PCR Technology
Chromatography Market
Others
EMEA Biotechnology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Health
Food & Agriculture
Natural Resources & Environment
Industrial Processing
Bioinformatics
Others
EMEA Biotechnology Market: Players Segment Analysis (Company and Product introduction, Biotechnology Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd
Pfizer
Merck & Co.
Sanofi
AstraZeneca
Gilead
CELGENE CORPORATION
Biogen
Amgen, Inc
Abbott
Novo Nordisk A/S
Novartis AG
Lonza
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BIOTECHNOLOGY
1.1 Definition of Biotechnology in This Report
1.2 Commercial Types of Biotechnology
1.2.1 DNA Sequencing
1.2.2 Nanobiotechnology
1.2.3 Tissue engineering and Regeneration
1.2.4 Fermentation
1.2.5 Cell Based Assay
1.2.6 PCR Technology
1.2.7 Chromatography Market
1.2.8 Others
1.3 Downstream Application of Biotechnology
1.3.1 Health
1.3.2 Food & Agriculture
1.3.3 Natural Resources & Environment
1.3.4 Industrial Processing
1.3.5 Bioinformatics
1.3.6 Others
1.4 Development History of Biotechnology
1.5 Market Status and Trend of Biotechnology 2013-2023
1.5.1 EMEA Biotechnology Market Status and Trend 2013-2023
1.5.2 Regional Biotechnology Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Biotechnology in EMEA 2013-2017
2.2 Consumption Market of Biotechnology in EMEA by Regions
2.2.1 Consumption Volume of Biotechnology in EMEA by Regions
2.2.2 Revenue of Biotechnology in EMEA by Regions
2.3 Market Analysis of Biotechnology in EMEA by Regions
2.3.1 Market Analysis of Biotechnology in Europe 2013-2017
2.3.2 Market Analysis of Biotechnology in Middle East 2013-2017
2.3.3 Market Analysis of Biotechnology in Africa 2013-2017
2.4 Market Development Forecast of Biotechnology in EMEA 2018-2023
2.4.1 Market Development Forecast of Biotechnology in EMEA 2018-2023
2.4.2 Market Development Forecast of Biotechnology by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Biotechnology in EMEA by Types
3.1.2 Revenue of Biotechnology in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Biotechnology in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biotechnology in EMEA by Downstream Industry
4.2 Demand Volume of Biotechnology by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biotechnology by Downstream Industry in Europe
4.2.2 Demand Volume of Biotechnology by Downstream Industry in Middle East
4.2.3 Demand Volume of Biotechnology by Downstream Industry in Africa
4.3 Market Forecast of Biotechnology in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOTECHNOLOGY
5.1 EMEA Economy Situation and Trend Overview
5.2 Biotechnology Downstream Industry Situation and Trend Overview
CHAPTER 6 BIOTECHNOLOGY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Biotechnology in EMEA by Major Players
6.2 Revenue of Biotechnology in EMEA by Major Players
6.3 Basic Information of Biotechnology by Major Players
6.3.1 Headquarters Location and Established Time of Biotechnology Major Players
6.3.2 Employees and Revenue Level of Biotechnology Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIOTECHNOLOGY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Johnson & Johnson Services, Inc.
7.1.1 Company profile
7.1.2 Representative Biotechnology Product
7.1.3 Biotechnology Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services, Inc.
7.2 F. Hoffmann-La Roche Ltd
7.2.1 Company profile
7.2.2 Representative Biotechnology Product
7.2.3 Biotechnology Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd
7.3 Pfizer
7.3.1 Company profile
7.3.2 Representative Biotechnology Product
7.3.3 Biotechnology Sales, Revenue, Price and Gross Margin of Pfizer
7.4 Merck & Co.
7.4.1 Company profile
7.4.2 Representative Biotechnology Product
7.4.3 Biotechnology Sales, Revenue, Price and Gross Margin of Merck & Co.
7.5 Sanofi
7.5.1 Company profile
7.5.2 Representative Biotechnology Product
7.5.3 Biotechnology Sales, Revenue, Price and Gross Margin of Sanofi
7.6 AstraZeneca
7.6.1 Company profile
7.6.2 Representative Biotechnology Product
7.6.3 Biotechnology Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 Gilead
7.7.1 Company profile
7.7.2 Representative Biotechnology Product
7.7.3 Biotechnology Sales, Revenue, Price and Gross Margin of Gilead
7.8 CELGENE CORPORATION
7.8.1 Company profile
7.8.2 Representative Biotechnology Product
7.8.3 Biotechnology Sales, Revenue, Price and Gross Margin of CELGENE CORPORATION
7.9 Biogen
7.9.1 Company profile
7.9.2 Representative Biotechnology Product
7.9.3 Biotechnology Sales, Revenue, Price and Gross Margin of Biogen
7.10 Amgen, Inc
7.10.1 Company profile
7.10.2 Representative Biotechnology Product
7.10.3 Biotechnology Sales, Revenue, Price and Gross Margin of Amgen, Inc
7.11 Abbott
7.11.1 Company profile
7.11.2 Representative Biotechnology Product
7.11.3 Biotechnology Sales, Revenue, Price and Gross Margin of Abbott
7.12 Novo Nordisk A/S
7.12.1 Company profile
7.12.2 Representative Biotechnology Product
7.12.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
7.13 Novartis AG
7.13.1 Company profile
7.13.2 Representative Biotechnology Product
7.13.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novartis AG
7.14 Lonza
7.14.1 Company profile
7.14.2 Representative Biotechnology Product
7.14.3 Biotechnology Sales, Revenue, Price and Gross Margin of Lonza
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOTECHNOLOGY
8.1 Industry Chain of Biotechnology
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOTECHNOLOGY
9.1 Cost Structure Analysis of Biotechnology
9.2 Raw Materials Cost Analysis of Biotechnology
9.3 Labor Cost Analysis of Biotechnology
9.4 Manufacturing Expenses Analysis of Biotechnology
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOTECHNOLOGY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Biotechnology in This Report
1.2 Commercial Types of Biotechnology
1.2.1 DNA Sequencing
1.2.2 Nanobiotechnology
1.2.3 Tissue engineering and Regeneration
1.2.4 Fermentation
1.2.5 Cell Based Assay
1.2.6 PCR Technology
1.2.7 Chromatography Market
1.2.8 Others
1.3 Downstream Application of Biotechnology
1.3.1 Health
1.3.2 Food & Agriculture
1.3.3 Natural Resources & Environment
1.3.4 Industrial Processing
1.3.5 Bioinformatics
1.3.6 Others
1.4 Development History of Biotechnology
1.5 Market Status and Trend of Biotechnology 2013-2023
1.5.1 EMEA Biotechnology Market Status and Trend 2013-2023
1.5.2 Regional Biotechnology Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Biotechnology in EMEA 2013-2017
2.2 Consumption Market of Biotechnology in EMEA by Regions
2.2.1 Consumption Volume of Biotechnology in EMEA by Regions
2.2.2 Revenue of Biotechnology in EMEA by Regions
2.3 Market Analysis of Biotechnology in EMEA by Regions
2.3.1 Market Analysis of Biotechnology in Europe 2013-2017
2.3.2 Market Analysis of Biotechnology in Middle East 2013-2017
2.3.3 Market Analysis of Biotechnology in Africa 2013-2017
2.4 Market Development Forecast of Biotechnology in EMEA 2018-2023
2.4.1 Market Development Forecast of Biotechnology in EMEA 2018-2023
2.4.2 Market Development Forecast of Biotechnology by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Biotechnology in EMEA by Types
3.1.2 Revenue of Biotechnology in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Biotechnology in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biotechnology in EMEA by Downstream Industry
4.2 Demand Volume of Biotechnology by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biotechnology by Downstream Industry in Europe
4.2.2 Demand Volume of Biotechnology by Downstream Industry in Middle East
4.2.3 Demand Volume of Biotechnology by Downstream Industry in Africa
4.3 Market Forecast of Biotechnology in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOTECHNOLOGY
5.1 EMEA Economy Situation and Trend Overview
5.2 Biotechnology Downstream Industry Situation and Trend Overview
CHAPTER 6 BIOTECHNOLOGY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Biotechnology in EMEA by Major Players
6.2 Revenue of Biotechnology in EMEA by Major Players
6.3 Basic Information of Biotechnology by Major Players
6.3.1 Headquarters Location and Established Time of Biotechnology Major Players
6.3.2 Employees and Revenue Level of Biotechnology Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIOTECHNOLOGY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Johnson & Johnson Services, Inc.
7.1.1 Company profile
7.1.2 Representative Biotechnology Product
7.1.3 Biotechnology Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services, Inc.
7.2 F. Hoffmann-La Roche Ltd
7.2.1 Company profile
7.2.2 Representative Biotechnology Product
7.2.3 Biotechnology Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd
7.3 Pfizer
7.3.1 Company profile
7.3.2 Representative Biotechnology Product
7.3.3 Biotechnology Sales, Revenue, Price and Gross Margin of Pfizer
7.4 Merck & Co.
7.4.1 Company profile
7.4.2 Representative Biotechnology Product
7.4.3 Biotechnology Sales, Revenue, Price and Gross Margin of Merck & Co.
7.5 Sanofi
7.5.1 Company profile
7.5.2 Representative Biotechnology Product
7.5.3 Biotechnology Sales, Revenue, Price and Gross Margin of Sanofi
7.6 AstraZeneca
7.6.1 Company profile
7.6.2 Representative Biotechnology Product
7.6.3 Biotechnology Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 Gilead
7.7.1 Company profile
7.7.2 Representative Biotechnology Product
7.7.3 Biotechnology Sales, Revenue, Price and Gross Margin of Gilead
7.8 CELGENE CORPORATION
7.8.1 Company profile
7.8.2 Representative Biotechnology Product
7.8.3 Biotechnology Sales, Revenue, Price and Gross Margin of CELGENE CORPORATION
7.9 Biogen
7.9.1 Company profile
7.9.2 Representative Biotechnology Product
7.9.3 Biotechnology Sales, Revenue, Price and Gross Margin of Biogen
7.10 Amgen, Inc
7.10.1 Company profile
7.10.2 Representative Biotechnology Product
7.10.3 Biotechnology Sales, Revenue, Price and Gross Margin of Amgen, Inc
7.11 Abbott
7.11.1 Company profile
7.11.2 Representative Biotechnology Product
7.11.3 Biotechnology Sales, Revenue, Price and Gross Margin of Abbott
7.12 Novo Nordisk A/S
7.12.1 Company profile
7.12.2 Representative Biotechnology Product
7.12.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
7.13 Novartis AG
7.13.1 Company profile
7.13.2 Representative Biotechnology Product
7.13.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novartis AG
7.14 Lonza
7.14.1 Company profile
7.14.2 Representative Biotechnology Product
7.14.3 Biotechnology Sales, Revenue, Price and Gross Margin of Lonza
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOTECHNOLOGY
8.1 Industry Chain of Biotechnology
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOTECHNOLOGY
9.1 Cost Structure Analysis of Biotechnology
9.2 Raw Materials Cost Analysis of Biotechnology
9.3 Labor Cost Analysis of Biotechnology
9.4 Manufacturing Expenses Analysis of Biotechnology
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOTECHNOLOGY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
